1-2 of 2
Paul N. Bogner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Up-Regulation of Peroxiredoxin 1 in Lung Cancer and Its Implication as a Prognostic and Therapeutic Target

Available to Purchase
Joo-Heon Kim, Paul N. Bogner, Sun-Hee Baek, Nithya Ramnath, Ping Liang, Hak-Ryul Kim, Chris Andrews, Young-Mee Park
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (8): 2326–2333.
https://doi.org/10.1158/1078-0432.CCR-07-4457
Published: 15 April 2008
View articletitled, Up-Regulation of Peroxiredoxin 1 in Lung Cancer and Its Implication as a Prognostic and Therapeutic Target
Open the PDF for Up-Regulation of Peroxiredoxin 1 in Lung Cancer and Its Implication as a Prognostic and Therapeutic Target in another window
Journal Articles

Elevated Peroxiredoxin 1, but not NF-E2–Related Factor 2, Is an Independent Prognostic Factor for Disease Recurrence and Reduced Survival in Stage I Non–Small Cell Lung Cancer

Available to Purchase
Joo-Heon Kim, Paul N. Bogner, Nithya Ramnath, Yoorim Park, Jihnhee Yu, Young-Mee Park
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (13): 3875–3882.
https://doi.org/10.1158/1078-0432.CCR-06-2893
Published: 02 July 2007
View articletitled, Elevated Peroxiredoxin 1, but not NF-E2–Related Factor 2, Is an Independent Prognostic Factor for Disease Recurrence and Reduced Survival in Stage I Non–Small Cell Lung Cancer
Open the PDF for Elevated Peroxiredoxin 1, but not NF-E2–Related Factor 2, Is an Independent Prognostic Factor for Disease Recurrence and Reduced Survival in Stage I Non–Small Cell Lung Cancer in another window